In Antiangiogenic Agents in Cancer Therapy, Beverly Teicher and a panel of distinguished investigators survey the state-of-the-art of antiangiogenesis research from the lab bench to clinical trials. Timely and authoritative, the contributors summarize our current understanding of tumor growth and it...

Full description

Bibliographic Details

Other Authors:	Teicher, Beverly A. (Editor)
Format:	Electronic eBook
Language:	English
Published:	Totowa, NJ Humana Press 1999
Series:	Cancer Drug Discovery and Development
Subjects:	Oncology Surgical Oncology Cancer Research Oncology   Surgical oncology Pharmakotherapie Vaskularisation Krebs > Medizin Angiogenese Inhibition Aufsatzsammlung
Online Access:	UBR01 Volltext
Summary:	In Antiangiogenic Agents in Cancer Therapy, Beverly Teicher and a panel of distinguished investigators survey the state-of-the-art of antiangiogenesis research from the lab bench to clinical trials. Timely and authoritative, the contributors summarize our current understanding of tumor growth and its dependence on vascular development, as well as the present status of antiangiogenic agents in preclinical and clinical development. In addition, the book also examines what is known about the mechanisms by which these therapeutic agents interfere with tumor vasculature and grapples with the problem of establishing criteria by which to assess their clinical efficacy. Antiangiogenic Agents in Cancer Therapy offers a unique cutting-edge compendium of antiangiogenic research, taking stock of what has been accomplished, where the experimental therapeutics of antiangiogenic agents are going, and the continuing evolution of their role in cancer treatment and novel drug development. Comprehensive and up-to-date, this book constitutes a key resource-rich in novel means and methods-for the clinical development of this important, highly promising new class of anticancer drugs
Physical Description:	1 Online-Ressource (XI, 450 p. 37 illus., 1 illus. in color)
ISBN:	9781592594535
DOI:	10.1007/978-1-59259-453-5